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We describe an unusual case of severe acute protein-losing enteropathy in a dog, which
presented with a systemic inflammatory response syndrome. This dog’s condition could
not be categorized as any well-known canine intestinal condition. Instead, components
of several enteropathies like acute hemorrhagic diarrhea syndrome (AHDS), chronic
inflammatory enteropathy (CIE), and ulcerative and granulomatous colitis were present.
Thorough investigations identified concurrent exocrine pancreatic insufficiency (EPI)
and hypocobalaminemia. On histopathology, marked diffuse chronic-active ileitis and
ulcerative colitis with fibroplasia and neovascularization were present. Intestinal biopsy
cultures identified E.coli and multiresistant Enterococcus spp. The latter was identified
as mucosally invasive using fluorescent in situ hybridization (FISH). Protracted clinical
signs following the acute presentation required intensive care including enteral and
parenteral feeding for a successful outcome, but eventually stabilized with antibiotics
and immunosuppressive doses of glucocorticoids. This case highlights a potentially
previously unrecognized condition, suspected to be a form of CIE manifesting acutely
after bacterial mucosal invasion. In this case, this might have been facilitated by EPI-
induced dysbiosis. The use of FISH and mucosal culture in this context provided
important clinical information and should be considered more frequently in CIE and
non-responsive AHDS.
Keywords: ulcerative colitis, protein-losing enteropathy, adherent-invasive, hemorrhagic gastroenteritis,
fluorescent in-situ hybridization
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INTRODUCTION
In this report, we describe a dog presenting to a tertiary referral
hospital for acute gastrointestinal (GI) signs accompanied
by severe protein loss, typically seen with chronic intestinal
disease, such as a lymphoplasmacytic enteritis or alimentary
lymphoma, leading to protein-losing enteropathy (PLE) (1).
Even though some extent of protein loss can be seen with other
forms of enteritis [e.g., parvovirosis (2), acute hemorrhagic
diarrhea syndrome (AHDS) (3)], these are characterized by
additional typical clinicopathological abnormalities, which
were absent in this case. This dog was also found to have
concurrent exocrine pancreatic insufficiency (EPI). Despite
appropriate treatment, the dog continued to experience rapid
clinical deterioration and worsening weight and protein
loss. Intensive care and assisted nutrition were required,
along with further investigations for an underlying cause.
Gastroduodeno- and colo-ileoscopy identified macroscopic
colonic ulceration. A form of granulomatous colitis (GC)
was suspected, as this can present with systemic malaise
and PLE (4). However, histological assessment of mucosal
pinch biopsies revealed no granulomas or PAS-positive
macrophage infiltration, as is typically seen in GC (5), but
marked ileitis and diffuse ulcerative colitis, reminiscent of
human inflammatory bowel disease (IBD) (6). Fluorescent
in-situ hybridization (FISH) identified a mucosally invasive
Enterococcus spp. and a multiresistant Enterococcus faecium was
cultured from the biopsies. This bacterium has only recently been
reported in cultures from dogs with GC (4) and has not been
documented within the tissues using FISH. Dogs with chronic
inflammatory enteropathies (CIE) are known to harbor invasive
Enterobacteriacea and E.coli, but not specifically Enterococcus
(7, 8). This dog eventually responded to a combination therapy
of hydrolyzed protein diet, antimicrobials, pancreatic enzyme,
and cobalamin supplementation and immunosuppression, as
well as supportive management.
This case highlights a potentially previously unrecognized
condition in dogs that shares some, but not all, characteristics
of several well-known enteropathies of the canine GI tract.
Components of AHDS, PLE, and GC were present, but
insufficient to fully classify as any of these conditions alone.
We speculate that this dog suffered from a form of CIE with
acute deterioration due to bacterial mucosal invasion, possibly
facilitated by EPI–induced dysbiosis (9).
CASE DESCRIPTION
Case Presentation and Initial Stabilization
A 3-years and 6-months-old male neutered cross breed
(Cockerspaniel and Poodle) dog presented as an urgent referral to
our hospital. The dog had suffered from acute onset progressive
hemorrhagic diarrhea with tenesmus and increased defecation
frequency over the previous 3 days. He had also become
increasingly lethargic and inappetent over 24 h. No retching,
vomiting, or regurgitation were reported, but the dog had lost
approximately 3 kg of weight since last recorded 6 months prior.
The recorded canine IBD activity index (CIBDAI) at presentation
was 8 (moderate) (10). Blood work performed at the referring
veterinary surgeon (RVS) prior to presentation revealed only
moderate elevations in hepatic enzymes, ALT and ALP (Table 1).
Physical examination revealed poor muscle and body
condition (2/9), with a weight of 7.8 kg, dull mentation, a heart
rate of 144 bpm, breathing rate of 24 bpm and 102.02◦F body
temperature. Mucous membranes were tacky and pale, with a
delayed capillary refill time (3 s), and a skin tent was present.
There was a mild diffuse abdominal discomfort and borderline
hypotension (systolic 109 mmHg, Doppler).
While pending initial investigations, supportive care
was initiated, consisting of an intravenous (IV) crystalloid
fluid replacement, IV buprenorphine (0.02 mg/kg TID) and
maropitant (1 mg/kg SID).
First Line Diagnostic Investigations and
Management
In-house blood tests revealed a PCV of 44% with total solids
of 54 g/dl, normal electrolytes, glucose, lactate, and creatinine,
but moderate hypoalbuminemia and elevations in hepatic
enzymes and bilirubin (Table 1). Neutropenia with left shift
was detected on in-house blood smear evaluation. Coagulation
times (activated partial thromboplastin time and prothrombin
time) were within reference ranges (Table 2). A point-of-care
abdominal ultrasound revealed no free peritoneal fluid. Fecal
parvovirus antigen test and a canine pancreatic lipase Snap test
were negative.
Hematology confirmed a marked left-shifted neutropenia
and revealed moderate monocytosis and mild non-
regenerative anemia. Serum biochemistry confirmed a
moderate hypoalbuminemia and hepatic enzyme elevation
(Table 1). Normal urine protein creatinine ratio and
basal cortisol excluded protein-losing nephropathy and
hypoadrenocorticism, respectively, (Table 2) as possible causes
for hypoalbuminemia (1, 11).
Abdominal radiographs identified a mild loss of serosal detail.
Full abdominal ultrasound revealed a corrugated duodenum
and overall thickening of the jejunal (3.7mm) and colonic wall
(4mm). Intestinal wall layering was intact, but numerous gas
artifacts extended into the jejunal submucosa, interpreted as
deep ulcers (Figure 1A). Evidence of moderate local steatitis
was identified along with jejunal lymph node enlargement
(13mm) and intracapsular gas (Figure 1B). A colic lymph node
was also prominent (5.6mm) and there was mild peritoneal
effusion. The liver was of normal size, diffusely hyperechoic
with mild distension of the intrahepatic bile ducts. There
was mild gall bladder wall edema, but no distension of the
common bile duct or evidence of obstruction. Several splenic
hypoechoic lesions (up to 8mm) were also detected. In-
house analysis of the peritoneal fluid was consistent with
a modified transudate (Table 2). Cytological examination of
hepatic fine needle aspirates (FNA) showed evidence of mild
lipidosis and cholestasis, while intestinal lymph node FNAs were
consistent with lymphoid reactivity, and splenic FNAs revealed
extramedullary hematopoiesis.
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TABLE 1 | Weight, hematology, biochemistry, and electrolyte monitoring results throughout hospitalization.
Parameter Ref range RVS Day-2 Day 1 Day 2 Day 3 Day 4 Day 10 Day 12 Day 14 Day 18 disc. Day 35
revisit
Day 56
revisit
Hematology
Neutrophils 3.6–12 x109/L 8 0.31 5.4 46 21.294 11
Lymphocytes 0.7–4.8 x109/L 1.8 2.01 2.75 5.42 0.936 1.024
Monocytes 0–1.5 x109/L 0.7 2.89 0.7 2.17 1.17 0.64
RBC 5.5–8.5 x1012/L 7.75 7.22 6.23 4.39 5.47 5.63
PCV 0.39–0.55 l/l 0.48 0.42 0.39 0.3 0.39 0.39
Biochemistry
Albumin 26–35 g/L 26 22 18.1 17 16.5 16.5 17.9 26.6 37.4 36.9
Globulin 18–37 g/L 34 32 21.7 23.6 28 26.3 27.8 31 25 25.7
Triglyceride 0.57–1.14 mmol/l 1.27 1.28 1.07 2.49 2.14 1.34 3.91 2.29
ALT 21–102 u/L 687 683 464 240 140 54 64 41 37 34 37
ALP 20–60 u/L 464 437 275 322 494 341 313 239 206 67 81
Bile Acids 0–7 µmol/l 50 24.3 27.3 22.4 6.8 34.6 8.6 4.9
Bilirubin 0–6.8 µmol/l 46.7 15.7 75.4 46.7 6.8 5.5 2.1 0.4 0.8 0.4
Urea 1.7–7.4 mmol/l 2.8 0.9 0.9 1.5 0.9 1 2.3 2 2.3 2.5 4.5
Clinical parameters
Weight kg 7.8 7.8 7.8 7.8 7.6 7.7 7.8 7.4 7.6 7.6
CIBDAI 0–3 insignif, 4–5 mild,
6–8 mod, >9 severe
8 9 11 7 4 3
Bed-Side tests
PCV 40–55% 44 43 40 55 29 33
TS 60–70 g/dL 54 46 50 50 48 46
Lactate < 2.5 mmol/l 0.7 0.9 1.5 1.1 1.1
Bold text indicates out with reference ranges. disc, discharge.
Chronic hepatic failure was a differential diagnosis for
hypoalbuminemia, but not further supported by the laboratory
findings [normoglycemia, normal coagulation times, and post-
prandial bile acids within the reference range (Table 2)].
Acute hepatitis seemed less likely as it tends to present with
higher bilirubin values and hepatic enzyme activities (12),
and would not explain the marked gastrointestinal changes
observed. However, infectious disease like Leptospirosis could
not be excluded, especially as the hospital is situated in an
endemic area and the dog’s vaccinations were overdue. Hence
Leptospirosis testing was performed (Table 2) and antimicrobial
treatment (IV potentiated amoxicillin) appropriate to reduce
Leptospira shedding was initiated. Not only is this hospital
policy (due to the zoonotic potential of Leptospirosis), but was
also considered acceptable due to the dog’s critical condition,
and would be suitable as treatment for suspected systemic
inflammatory response syndrome (SIRS) (13) or suspected
cholangitis/cholangiohepatitis caused by an ascending infection
from the GI tract. Sampling the bile prior to starting antibiotics
would have been ideal to allow treatment based on the culture
and sensitivity testing (14).
Subsequent diagnostic tests included fecal parasitology,
routine culture, and clostridial testing (all negative). Serum
trypsin–like immunoreactivity (TLI), folate, and cobalamin
levels were assessed, revealing both the presence of EPI and
hypocobalaminemia (Table 2).
Advanced Diagnostic Investigations and
Subsequent Management
Cardiovascular parameters were stabilized and hepatic
parameters improved with continued IV fluid therapy and
parenteral drug administration, consisting of IV antibiotics
[potentiated amoxicillin (20 mg/kg TID) and metronidazole
(10 mg/kg BID)], pantoprazole (1 mg/kg BID), buprenorphine
(reduced to 0.01 mg/kg TID on day 4, and discontinued on
day 6), maropitant (1 mg/kg SID) as needed, and cobalamin
injections (400 µg weekly from day 5). Despite these treatments,
anorexia continued, prompting the provision of enteral
nutrition1 via a naso-esophageal tube (from day 4). Oral
pancreatic enzyme supplementation2 was initiated on day 7.
Watery hemorrhagic diarrhea continued with additional fecal
incontinence, regurgitation, and vomiting developing, which
increased CIBDAI to 11 (Table 1). Vomiting responded to a
continuous rate infusion of metoclopramide (2 mg/kg/day).
1Royal Canin GI Low Fat Liquid, Crown Pet Foods, Somerset, UK.
2Lypex Pancreatic Enzyme Sprinkle Capsules for dogs, VetPlus Tangerine Group,
Lytham, UK.
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TABLE 2 | Non-repeated and ancillary tests.
Parameter Result Ref range
TLI <1 6.1–35 µg/L
Cobalamin 251 >275 ng/L
Folate 6.2 8.2–13.5 µg/L
Cortisol 204 20–230 nmol/l
Bile Acids (post-prandial) 27.3 0–7 µmol/l
NH3 28 0–98 µmol/l
USG 1.005 > 1.030
Urine dipstick pH 8, 1+protein,
UPC 0.4 <0.5
cPL snap test Negative
Free fluid analysis SG 1.020, some
neutrophils,
macrophages, and
mesothelial cells
Fecal parvovirus antigen test Negative
Fecal flotation/sedimentation No parasites, Giardia
antigen negative
Fecal Clostridium perfringens
PCR and toxins
Negative
Leptospirosis PCR (urine) Negative
Leptospirosis MAT
L. icteroheamorrhagiae
L. canicola
L. hardjo
L. pomona
L. grippotyphosa
L. bratislava
Negative at 1:100
Negative at 1:100
Negative at 1:50
Negative at 1:100
Negative at 1:100
Negative at 1:100
aPTT 66 72–102 s
PT 12 12 s
Bold text indicates out with reference range.
Body weight remained stable over the first 4 days then dropped,
later accompanied by a further decrease in the serum albumin
(Table 1 and Figure 2) at day 7 of hospitalization.
Increased risk of post-surgical dehiscence and a requirement
for colonic biopsies were both deterring factors for surgical
biopsies (15), so a diagnostic upper and lower GI endoscopy
was performed. As hepatic parameters were stable with no signs
of developing hepatic dysfunction or hepatic encephalopathy,
hepatic biopsies were not considered pertinent at this stage.
An esophagostomy tube and central venous line were placed
to enable improved provision of nutrition and monitoring.
Endoscopy revealed mild gastroduodenal hyperemia andmarked
generalized colonic hyperemia with diffuse circular erosions of
∼1 cm in diameter. The colon and cecum were friable and
bled easily with endoscopic manipulations. The ileum appeared
firm with hyperemic striations, but no gross mucosal erosions
(Figures 1C–E). After the endoscopy, parenteral enrofloxacin (5
mg/kg BID) was initiated for presumed GC (16, 17).
Histology revealed mild diffuse lymphoplasmacytic
gastritis and moderate diffuse chronic duodenitis. The main
abnormalities were a moderate diffuse, chronic-active, and
mildly eosinophilic ileitis, and marked diffuse, subacute,
ulcerative colitis with an overlying fibrino-suppurative exudate,
marked fibroplasia, and neovascularisation (Figures 3A,B).
The predominant colonic cellular infiltrate were neutrophils,
followed by the lymphocytes and monocytes. Colonic samples
were subsequently stained with a Periodic acid–Schiff (PAS) to
assess macrophages typical of GC (Figures 3C,D); and Grocott’s
methenamine silver for fungi, protozoa, or prototheca algae; both
were negative (Figure 4A). Gram-staining identified surface or
mucosal exudate gram-positive bacteria (Figure 4B).
Serum albumin continued to decrease despite ongoing
esophagostomy tube enteral feeding, so partial parenteral
nutrition (PPN) was started. In addition, treatment with
immunosuppressive doses of glucocorticoids (0.3 mg/kg
dexamethasone IV SID) was initiated for presumed underlying
CIE, while pending FISH.
Snap frozen colonic and ileal samples were submitted for
bacterial culture. A multi-resistant Enterococcus faecium and an
E.coli were isolated from both sites.
FISH showed no ileal bacterial invasion but diffuse clusters of
invasive cocci within the colonicmucosa (eubacterial probe EUB-
338). Specific probes were negative for E.coli but confirmed an
intramucosal Enterococcus spp. (Figures 4C,D).
Treatment and Outcome
Treatment beyond stabilization and tailored IV fluid therapy
consisted of antimicrobials, gastroprotection, antiemetics,
analgesia oral pancreatic enzymes2, and parenteral cobalamin,
as outlined above. When negative Leptospirosis test results
were available, potentiated amoxicillin was discontinued.
Metronidazole was administered for a total of 21 days and
dexamethasone was switched to oral prednisolone (2 mg/kg/day)
on day 14 (Figure 2).
On day 13, a repeat abdominal ultrasound was performed,
revealing a significant improvement; the previously reported
hepatic duct dilation, gall bladder edema, free peritoneal
fluid, and small intestinal wall changes had resolved. The
jejunal lymph nodes no longer contained gas and were of
normal size. However, the wall of the descending colon and
cecum remained thickened (4mm) with two discrete areas
of ulceration. The colic and ileocecal lymph nodes were
mildly enlarged.
Fecal characteristics improved and the overall CIBDAI
reduced to 4 alongside an increased serum albumin on day
18 (Table 1 and Figure 2), when the dog was discharged.
Prednisolone was reduced to 1.3 mg/kg/day at this point.
A commercially available hydrolyzed food3,4 was continued,
however, the owner decided to change to home-cooked white fish
and rice. On day 20, additional dietary fiber5 was prescribed to
improve fecal consistency. By the time FISH and biopsy culture
results were received, the dog had improved dramatically, so no
further treatment amendments weremade. Oral enrofloxacin was
continued for a total of 6 weeks (Figure 2), as recommended for
E.coli associated GC (4, 16).
3Royal Canin Hypoallergenic, Crown Pet Foods, Somerset, UK.
4Royal Canin Anallergenic, Crown Pet Foods, Somerset, UK.
5FiborTM , VetPlus Tangerine Group, Lytham, UK.
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FIGURE 1 | Images from the initial abdominal ultrasound (A,B) and endoscopy (C–E). (A) Jejunal ulcerations with gas inclusions (red arrows). (B) Enlarged jejunal
lymph node with gas (red arrows). (C,D) Colonic mucosa showing marked generalized hyperemia with small (∼1 cm diameter) and diffuse colonic circular erosions. (E)
Ileum mucosa with hyperemia and striations.
FIGURE 2 | Timeline of the dog’s clinical course and treatments. Serum albumin values are depicted in the orange line; the reference interval indicated by the faint
orange background. The dog’s body weight is depicted in the blue line. Pink stars indicate cobalamin injections. Details about the products and dosages can be found
in the main text.
Cobalamin (400 µg) was administered parenterally weekly for
6 weeks, then again after a further month and retested by the RVS
(Figure 2). As it was below the reference range and remained low
with biweekly injections thereafter, daily oral supplementation
was recommended indefinitely.
On day 35, the dog was found to be stable, so prednisolone
was reduced to 1 mg/kg/day. On day 56, further weight loss was
observed (Table 1 and Figure 2) and stools were reported as a
cow-pat consistency, so a strict elimination diet was reinstated
and a multi-strain probiotic blend6 was prescribed. Prednisolone
was reduced to 0.7 mg/kg/day. At the same visit, generalized
pruritus, diffuse alopecia, and skin erythema were noted, and
the dog was diagnosed with additional atopic dermatitis by
a dermatologist.
6SivoyTM (rebranded SivoMixxTM in 2018), Omendes SA, Neuilly Sur Marne,
France; via Natprod Ltd, London, UK.
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FIGURE 3 | Histopathology of the colonic pinch biopsies. (A,B) H&E (20x) with intact crypts (A) and overlying fibrino-suppurative exudate, and areas of complete
effacement of normal architecture (B) with inflammation and marked fibroplasia and neovascularization. (C) PAS (20x) with no PAS positive macrophages. (D) PAS
(40x) stained colon from a dog with E.coli–associated GC with PAS positive macrophages for comparative purposes.
FIGURE 4 | Histochemistry and FISH analysis of colonic biopsies. (A) Grocott stained section (40x) with no evidence of fungal elements. (B) Gram stain (60x) section
of the overlying colonic fibrino-suppurative exudate, showing Gram+ve bacteria. (C,D) FISH of mucosa with oligonucleotide probes against Eubacteria (C)
(Cy3-EUB-338-red / 6-FAM- Non-EUB 338 -green) and Enterococcus (D) (Cy3-Enterococcus-red / 6-FAM- Non-EUB-338 -green) reveals a cluster of invasive
intracellular Enterococcus spp. DAPI nuclear DNA (blue) counter-stain.
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Over the following months, the dog remained stable.
Prednisolone was tapered: 0.3mg/kg daily from day 89, 0.3mg/kg
EOD from day 100, and finally discontinued on day 123. Fiber
and probiotic supplementation were stopped on day 89.
On day 140, the dog’s body weight was 8.7 kg, and there
were no notable GI signs. Treatment consisted of indefinite
supplementation with pancreatic enzymes and oral cobalamin, as
well as oclacitinib7.
Serum albumin was reported to be stable on day 230. On day
434, the RVS reported the dog to be doing well, but no further
information on weight or blood values was available.
DISCUSSION
There are four main points that make this case unusual. First,
the dog’s acute clinical course was similar to AHDS but without a
response to appropriate supportive care. Second, marked protein
loss, similar to AHDS and CIE with PLE, was present but without
chronicity. Third, the histopathology findings were not typical for
any previously classified enteropathy, but had the characteristics
of several different intestinal conditions: GC, AHDS, and CIE.
Finally, multi-resistant invasive enterococci were present in the
colonic mucosa, which has not been identified in AHDS or GC
and is not typical of CIE.
Initial clinical signs and investigations were most consistent
with AHDS (with bacterial translocation and sepsis), though
these did not include hemoconcentration, vomiting, and
melena. The requirement for prolonged hospitalization (18
days), intermittent intensive care, PPN, and tube feeding, are
considered unusual for AHDS (3). SIRS, including a left-shifted
neutropenia (18), and worsening protein loss are also uncommon
in AHDS, though increasingly recognized (19). Antibiotics are
not routinely used in AHDS, as they do not influence the
clinical course (20), but were appropriate for SIRS, neutropenia,
and the later identified invasive bacteria in this case. Bacteria
usually associated with AHDS are non-invasive Clostridium spp.
expressing toxins (19, 21–23) and neither of these were detected
in this case.
Several canine GI conditions have been described resulting
in PLE (1), mainly subtypes of CIE or intestinal neoplasia, or
primary congenital intestinal lymphangiectasia. Typically, these
conditions present with gradually progressive chronic signs of
small intestinal diarrhea, anorexia, and/or vomiting, which was
not reported here. The dog’s historic weight loss could indicate
a more chronic malabsorptive disease, such as an “undetected”
CIE or subclinical EPI. Signs of “colitis” can be present in CIE,
but again would be typically chronic, less severe, and are more
commonly associated with mild food-responsive disease (24).
The histopathological findings do not fit into a recognized
category of canine conditions. Although focal erosions and a
neutrophilic infiltrate are seen in AHDS, the typical severe
necrosis (22) was not present. The mucosal ulcerations most
closely resemble lesions seen in human IBD, particularly Crohn’s
disease (CD) (25, 26), but these are not typical in canine
CIE. Erosions can be present in more acute viral and parasitic
7Apoquel R©, Zoetis UK Ltd., Leatherhead, UK.
infectious enteropathies, though parasite testing was negative.
In dogs, the most closely resembling condition is GC (16), a
distinct type of colitis in Boxers, French Bulldogs, and other
breeds (27–30) but not described in Cocker Spaniels or Poodles.
The typical histological features of a granulomatous infiltration
and PAS-positive macrophages (4) were not present in the case
presented here.
Invasive bacteria are a feature most typical of GC in dogs,
and adherent and invasive E.coli strains from Boxer GC have
reported phylogenetic similarities to the ones found in human
CD (4, 26). Invasive E.coli have also been identified in dogs
with CIE and intestinal neoplasia alongside other bacteria (7).
Intestinal dysbiosis is clearly described in human IBD, and E.coli
strains are considered to contribute (8), particularly to human
CD. There is evidence of gene polymorphisms linked to the
immune response and reduced bacterial killing (31) in human
IBD and marked differences in the immune subsets and response
have been identified (32). Causality can be difficult to prove, but
human IBD derived E. faecium has been shown to promote colitis
in an animal model (33).
However, invasive Enterococcus spp. have neither been
detected in canine GC, nor in conjunction with other colonic
inflammatory lesions in dogs. Invasive Enterococcus spp. has
only been reported in one other canine intestinal case, which
was Enterococcus durans causing diarrhea in a puppy (34).
Enterococci are frequently found in healthy dog feces (35), and
products containing E. faecium are the most frequently marketed
“probiotics” for small animals (36, 37). However, up to 61%
of fecal samples from healthy dogs contain multidrug resistant
enterococci (35). They can adhere to the mucus glycoproteins
from various different hosts in vitro (38, 39) and adherence
has been identified by FISH in kittens with diarrhea (40).
In addition, Enterococcus spp. are capable of evolving into
pathogens by virulence factor acquisition through mobile genetic
elements (41).
In this case, the Enterococcus spp. was invasive and therefore,
pathogenic, and could have also resulted in the hepatic and
biliary damage detected at presentation, as this is a common
pathogen in cholecystitis (42). It is unknown, however, if this was
the original cause or an opportunistic infection. Likewise, it is
unclear if the SIRS at presentation was related to true septicemia,
in which case a blood culture could have been beneficial, even
though it has been reported to not be of diagnostic help in dogs
with AHDS (18). It is not possible to assess if this bacterium
was an intestinal commensal, which only became pathogenic
secondary to an environmental change (a pathobiont), especially
given the dysbiosis known to be caused by an EPI (9), or if
it was a primary pathogen acquired from an environmental or
cohabital source.
Overall, this case demonstrates that canine GI conditions
other than GC are associated with mucosally invasive bacteria.
As FISH is not a routine diagnostic tool, the frequency of this
is unknown. FISH should be considered more frequently as part
of routine diagnostics like in human IBD (43–45), particularly in
severe or difficult to control cases. Results may identify different
underlying phenotypes of CIE, that more closely resemble human
CD. Further mechanistic understanding is important given the
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wide phenotypic variation of CIE, which remains one of the most
common, yet least understood, canine GI conditions (46).
As well as being informative of an unusual underlying
pathology, FISH could provide guidance on therapeutic plans,
especially with wider availability and faster results. In the
current case, this would likely have resulted in a change of
antibiotic management, as empirical enrofloxacin was not ideal.
Increasing resistance to enrofloxacin has already been reported
in GC–associated E.coli (47–49). Based on FISH and culture,
trimethoprim sulfonamide would have been more appropriate,
but as the dog had already improved considerably, a long course
of this was undesirable due to common significant side effects.
FISH and early intestinal mucosal cultures could, apart from the
benefit to the individual, also provide a method for pathogenic
bacterial surveillance. This is likely to be particularly important
with increasing global bacterial resistance, emergence of novel
potential pathogens (like a recent outbreak of hemorrhagic
diarrhea linked to Providencia alcalifaciens in Norway), and
detection of novel virulence factors (50, 51).
This dog eventually responded to a multimodal therapy for
CIE with invasive bacteria and EPI. Despite not falling within a
specifically known or described category of canine enteropathy,
monitoring of several clinical and clinicopathological parameters
similarly used in CIE and PLE was the key to creating an
appropriate diagnostic and therapeutic plan and to determine
treatment response and success. Hypoalbuminemia was an
important factor driving further investigations. In cases of
PLE, it seems particularly prudent to exclude intestinal
neoplasia as this would impact on the treatment plan and
prognosis. The magnitude of CIBDAI, hypoalbuminemia,
and hypocobalaminemia have been previously described as
prognostic indicators in dogs with CIE and PLE (24, 52).
However, in a recent study on canine PLE, no routine diagnostic
test was predictive of the outcome (53), which might limit the
use of these values for prognostication in individual dogs. The
dog described here was eventually managed with an elimination
diet alone, alongside long-term supplementation of pancreatic
enzymes cobalamin and treatment of subsequently diagnosed
atopic dermatitis. The fact that the dog could not tolerate other
commercial or home-cooked diets might further indicate an
underlying (and ongoing) CIE as a driver of the pathologies that
ultimately lead to the dramatic picture seen on presentation and
subsequent diagnostic tests. Even though dietary management
alone is also described for dogs with PLE (54, 55), this was
not an appropriate choice as the sole treatment given the
initial presentation and severity of the signs requiring prolonged
hospitalization in this case.
In summary, this unusual case defied the constraints of our
current categorical definitions of CIE, GC, and AHDS, having
more similarities to forms of human CD, and the details provided
herein could guide the clinical management of similar cases. The
use of FISH in the context of a seemingly acute GI presentation
provided important pathological detail and should be considered
more frequently.
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